Course Description:

This online course qualifies for 1.5 hours of CE credit that is automatically issued with a digital certificate upon completion.

New prescription drugs are consistently introduced to the market. With almost half of Americans taking at least one type of medication, it’s critical to patient safety to familiarize yourself with new drugs and their guidelines when interacting with sedation medication.

In this course presented by DOCS Education Medical Director, Leslie Fang, MD, PhD, he discusses the new oral anticoagulants (NOACs) that are effectively being prescribed in place of Coumadin, and the guidelines for determining dental management when they’re in use. He’ll also address new antiplatelet agents beyond Plavix and aspirin, as well as managing patients with double antiplatelet therapy.

Objectives:

Meet the new oral anticoagulants: Pradaxa, Xarelto, Eliquis and Savaysa ^{(920, 921, 922, 923, 924)}
Recognize each drug’s factors and interactions with sedation dentistry
Learn the antiplatelet agents beyond Plavix and baby aspirin
Determine the bleeding risk with NOACs and antiplatelet agents
Identify the drugs that are safe, and the ones to avoid

Purchase of this course grants access for one year and requires an internet connection, computer with video and audio capabilities, and in some cases, Adobe Reader to view handouts and articles.

You can download this course and watch it anywhere using the DOCS APP. Get it on Google Play or the Apple Store.